Literature DB >> 19968665

T cell sensitivity and the outcome of viral infection.

L J Walker1, A K Sewell, P Klenerman.   

Abstract

The importance of CD8(+) T cells in the control of viral infections is well established. However, what differentiates CD8(+) T cell responses in individuals who control infection and those who do not is not well understood. 'Functional sensitivity' describes an important quality of the T cell response and is determined in part by the affinity of the T cell receptor for antigen. A more sensitive T cell response is generally believed to be more efficient and associated with better control of viral infection, yet may also drive viral mutation and immune escape. Various in vitro techniques have been used to measure T cell sensitivity; however, rapid ex vivo analysis of this has been made possible by the application of the 'magic' tetramer technology. Such tools have potentially important applications in the design and evaluation of vaccines.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19968665      PMCID: PMC2819491          DOI: 10.1111/j.1365-2249.2009.04047.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  73 in total

1.  Discrepancy between ELISPOT IFN-gamma secretion and binding of A2/peptide multimers to TCR reveals interclonal dissociation of CTL effector function from TCR-peptide/MHC complexes half-life.

Authors:  V Rubio-Godoy; V Dutoit; D Rimoldi; D Lienard; F Lejeune; D Speiser; P Guillaume; J C Cerottini; P Romero; D Valmori
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-21       Impact factor: 11.205

2.  Analysis of 'driver' and 'passenger' CD8+ T-cell responses against variable viruses.

Authors:  Andreas Zafiropoulos; Eleanor Barnes; Clive Piggott; Paul Klenerman
Journal:  Proc Biol Sci       Date:  2004-02-07       Impact factor: 5.349

3.  CD8 kinetically promotes ligand binding to the T-cell antigen receptor.

Authors:  Dmitry M Gakamsky; Immanuel F Luescher; Aladdin Pramanik; Ronen B Kopito; François Lemonnier; Horst Vogel; Rudolf Rigler; Israel Pecht
Journal:  Biophys J       Date:  2005-06-24       Impact factor: 4.033

4.  Epitope-dependent avidity thresholds for cytotoxic T-lymphocyte clearance of virus-infected cells.

Authors:  Michael S Bennett; Hwee L Ng; Mirabelle Dagarag; Ayub Ali; Otto O Yang
Journal:  J Virol       Date:  2007-02-28       Impact factor: 5.103

5.  Relating TCR-peptide-MHC affinity to immunogenicity for the design of tumor vaccines.

Authors:  Rachel H McMahan; Jennifer A McWilliams; Kimberly R Jordan; Steven W Dow; Darcy B Wilson; Jill E Slansky
Journal:  J Clin Invest       Date:  2006-08-24       Impact factor: 14.808

6.  Differential expansion and survival of high and low avidity cytotoxic T cell populations during the immune response to a viral infection.

Authors:  M A Alexander-Miller
Journal:  Cell Immunol       Date:  2000-04-10       Impact factor: 4.868

7.  Interaction between the CD8 coreceptor and major histocompatibility complex class I stabilizes T cell receptor-antigen complexes at the cell surface.

Authors:  Linda Wooldridge; Hugo A van den Berg; Meir Glick; Emma Gostick; Bruno Laugel; Sarah L Hutchinson; Anita Milicic; Jason M Brenchley; Daniel C Douek; David A Price; Andrew K Sewell
Journal:  J Biol Chem       Date:  2005-04-18       Impact factor: 5.157

8.  HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function.

Authors:  V Appay; D F Nixon; S M Donahoe; G M Gillespie; T Dong; A King; G S Ogg; H M Spiegel; C Conlon; C A Spina; D V Havlir; D D Richman; A Waters; P Easterbrook; A J McMichael; S L Rowland-Jones
Journal:  J Exp Med       Date:  2000-07-03       Impact factor: 14.307

9.  Induction and exhaustion of lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes visualized using soluble tetrameric major histocompatibility complex class I-peptide complexes.

Authors:  A Gallimore; A Glithero; A Godkin; A C Tissot; A Plückthun; T Elliott; H Hengartner; R Zinkernagel
Journal:  J Exp Med       Date:  1998-05-04       Impact factor: 14.307

10.  Memory CD8+ T cells are required for protection from persistent hepatitis C virus infection.

Authors:  Naglaa H Shoukry; Arash Grakoui; Michael Houghton; David Y Chien; John Ghrayeb; Keith A Reimann; Christopher M Walker
Journal:  J Exp Med       Date:  2003-06-16       Impact factor: 14.307

View more
  14 in total

1.  Kinetically distinct processing pathways diversify the CD8+ T cell response to a single viral epitope.

Authors:  Gabriela L Cosma; Jenna L Lobby; Elizabeth J Fay; Nicholas A Siciliano; Ryan A Langlois; Laurence C Eisenlohr
Journal:  Proc Natl Acad Sci U S A       Date:  2020-07-27       Impact factor: 11.205

2.  Broadening the translational immunology landscape.

Authors:  M Peakman
Journal:  Clin Exp Immunol       Date:  2012-12       Impact factor: 4.330

3.  Inflammation in common variable immunodeficiency is associated with a distinct CD8(+) response to cytomegalovirus.

Authors:  Sayed Mahdi Marashi; Mohammad Raeiszadeh; Sarita Workman; Afsar Rahbar; Cecilia Soderberg-Naucler; Paul Klenerman; Ronnie Chee; A David Webster; Richard S B Milne; Vincent C Emery
Journal:  J Allergy Clin Immunol       Date:  2011-05-04       Impact factor: 10.793

4.  Interleukin-10 Directly Inhibits CD8+ T Cell Function by Enhancing N-Glycan Branching to Decrease Antigen Sensitivity.

Authors:  Logan K Smith; Giselle M Boukhaled; Stephanie A Condotta; Sabrina Mazouz; Jenna J Guthmiller; Rahul Vijay; Noah S Butler; Julie Bruneau; Naglaa H Shoukry; Connie M Krawczyk; Martin J Richer
Journal:  Immunity       Date:  2018-01-23       Impact factor: 31.745

5.  Pathogen-specific inflammatory milieux tune the antigen sensitivity of CD8(+) T cells by enhancing T cell receptor signaling.

Authors:  Martin J Richer; Jeffrey C Nolz; John T Harty
Journal:  Immunity       Date:  2012-12-20       Impact factor: 31.745

6.  Age-associated increase of low-avidity cytomegalovirus-specific CD8+ T cells that re-express CD45RA.

Authors:  Stephen J Griffiths; Natalie E Riddell; Joanne Masters; Valentina Libri; Sian M Henson; Anne Wertheimer; Diana Wallace; Stuart Sims; Laura Rivino; Anis Larbi; David M Kemeny; Janko Nikolich-Zugich; Florian Kern; Paul Klenerman; Vince C Emery; Arne N Akbar
Journal:  J Immunol       Date:  2013-05-01       Impact factor: 5.422

7.  In silico prediction of Ebola Zaire GP(1,2) immuno-dominant epitopes for the Balb/c mouse.

Authors:  Debargh K Dutta; Kelly Rhodes; Steven C Wood
Journal:  BMC Immunol       Date:  2015-10-06       Impact factor: 3.615

8.  CD8αα Expression Marks Terminally Differentiated Human CD8+ T Cells Expanded in Chronic Viral Infection.

Authors:  L J Walker; E Marrinan; M Muenchhoff; J Ferguson; H Kloverpris; H Cheroutre; E Barnes; P Goulder; Paul Klenerman
Journal:  Front Immunol       Date:  2013-08-06       Impact factor: 7.561

9.  Local CD4 and CD8 T-cell reactivity to HSV-1 antigens documents broad viral protein expression and immune competence in latently infected human trigeminal ganglia.

Authors:  Monique van Velzen; Lichen Jing; Albert D M E Osterhaus; Alessandro Sette; David M Koelle; Georges M G M Verjans
Journal:  PLoS Pathog       Date:  2013-08-15       Impact factor: 6.823

10.  Proximity of TCR and its CD8 coreceptor controls sensitivity of T cells.

Authors:  Jessica G Borger; Rose Zamoyska; Dmitry M Gakamsky
Journal:  Immunol Lett       Date:  2013-11-18       Impact factor: 3.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.